Mahajan Imaging & Labs Hosts Roundtable Conference on Integrated Diagnostics and Women Health
The roundtable explored key issues in women’s health, including cancer screening, mental well-being, and the role of integrated diagnostics in early disease detection.
Global Pharma | 12/03/2025 | By Aishwarya | 216
Viking Therapeutics Signs Multi-Year Manufacturing Deal with CordenPharma for Obesity Drug VK2735
Under the terms of the agreement, Viking has secured dedicated capacity for the manufacture of, and a commitment to supply annually, multiple metric tons of VK2735 API.
Global Pharma | 11/03/2025 | By Manvi | 453
Endo to Sale International Pharmaceuticals Business to Knight Therapeutics for USD 99 Million
Endo, Inc. has entered into a definitive agreement to sell its international pharmaceuticals business, primarily operated through Canada-based Paladin Pharma Inc., to Knight Therapeutics Inc. for a total consideration of up to USD 99 million.
Global Pharma | 11/03/2025 | By Manvi | 240
Momentum Biotechnologies Completes Acquisition of OmicScouts
With this transaction, Momentum gains access to a broad portfolio of well-validated proteomic assays that enhance and extend their existing service offerings, enabling clients to seamlessly progress from high-throughput screening into cell-based assays, as well as to discover new targets and biomarkers.
Global Pharma | 11/03/2025 | By Aishwarya | 218
Aragen Strengthens Leadership with Two Key Appointments
Jayadeva joins as the Vice President and Head of Chemical Development Solutions (CDS), one of the largest and critical businesses of Aragen.
Global Pharma | 11/03/2025 | By Aishwarya | 327
Govt of India Invites Proposals for Funding Under PRIP Scheme
The DoP is seeking participation from proprietary firms, partnership firms, limited liability partnerships, startups, and companies or groups of companies registered in India.
Global Pharma | 11/03/2025 | By Aishwarya | 535
Isotopia Launches Isoprotrace in Germany
Isotopia has officially launched Isoprotrace® in Germany. DSD Pharma, a trusted pharmaceutical distributor in Germany, will serve as the exclusive partner for the distribution of Isoprotrace® throughout the country, ensuring efficient, consistent delivery to hospitals, clinics, and diagnostic centres across Germany.
Global Pharma | 10/03/2025 | By Manvi | 147
Indoco's CRO AnaCipher Completed US FDA Inspection
Indoco Remedies Ltd. has announced that its Clinical Research Organisation, AnaCipher, located at Hyderabad, has completed its 5-day comprehensive USFDA inspection. The on-site inspection was conducted from March 3-7, 2025, by investigators from Bioresearch Monitoring Program (BIMO) and Office of Study Integrity & Surveillance (OSIS) of US FDA.
Global Pharma | 10/03/2025 | By Manvi | 363
Biocon Biologics and Civica to Expand Insulin Aspart Access in US
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials. No technology transfer is involved in the agreement.
Global Pharma | 10/03/2025 | By Aishwarya | 467
Sun Pharma to Acquire Checkpoint Therapeutics
Checkpoint has received approval from the US Food & Drug Administration (FDA) for UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation.
Global Pharma | 10/03/2025 | By Aishwarya | 245
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy